Follow
International Journal of Current Microbiology and Applied Sciences (IJCMAS)
IJCMAS is now DOI (CrossRef) registered Research Journal. The DOIs are assigned to all published IJCMAS Articles.
Index Copernicus ICI Journals Master List 2019 - IJCMAS--ICV 2019: 96.39 For more details click here
National Academy of Agricultural Sciences (NAAS) : NAAS Score: *5.38 (2020) [Effective from January 1, 2020]For more details click here

Login as a Reviewer

Indexed in



National Academy of Agricultural Sciences (NAAS)
NAAS Score: *5.38 (2020)
[Effective from January 1, 2020]
For more details click here

ICV 2019: 96.39
Index Copernicus ICI Journals Master List 2019 - IJCMAS--ICV 2019: 96.39
For more details click here

See Guidelines to Authors
Current Issues
Download Publication Certificate

Original Research Articles

PRINT ISSN : 2319-7692
Online ISSN : 2319-7706
Issues : 12 per year
Publisher : Excellent Publishers
Email : editorijcmas@gmail.com / submit@ijcmas.com
Editor-in-chief: Dr.M.Prakash
Index Copernicus ICV 2018: 95.39
NAAS RATING 2020: 5.38

Int.J.Curr.Microbiol.App.Sci.2021.10(9): 402-406
DOI: https://doi.org/10.20546/ijcmas.2021.1009.046


Covid - 19 Associated Pulmonary Aspergillosis (CAPA) in Critically Ill Patients : A Case Report
Himadri Dutta1*, Vandana Sinha2, Anup Jyoti Dutta2 and Pinku Sarma3
1Department of Microbiology, 2Department of Critical Care, 3Department of Radiology and Imaging, Critical care, Ayursundra Superspecialty Hospital, Gorchuk, Guwahati, Assam, India
*Corresponding author
Abstract:

In the present study report three cases of covid-19 associated Pulmonary Aspergillosis from covid ICU of a private hospital. There is increased incidence of different co infections including fungal from severe cases of covid-19 requiring ICU care from different parts of the world. None of the patients in our report had any predisposing lung conditions and none of them were on long term steroids treatment. Out of the three cases, two cases clinically improved dramatically after initiation of antifungals. Second case deteriorated even before culture diagnosis was established and the patient died before antifungals could be started. So, possibility of a fungal infection should be always ruled out in all COVID-19 pneumonia cases without any clinical improvement after standard treatment and intensive care. Early diagnosis and treatment will help improve clinical outcomes in such cases.


Keywords: Covid-19, pulmonary aspergillosis, CAPA, IAPA, Co infection
Download this article as Download

How to cite this article:

Himadri Dutta, Vandana Sinha, Anup Jyoti Dutta and Pinku Sarma. 2021. Covid -19 Associated Pulmonary Aspergillosis (CAPA) in Critically Ill Patients : A Case Report.Int.J.Curr.Microbiol.App.Sci. 10(9): 402-406. doi: https://doi.org/10.20546/ijcmas.2021.1009.046